Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-08-29

FDA Approved: BILPREVDA — Original Application (Organon LLC)

View source ↗

Summary

FDA approved Bilprevda (denosumab) under an original Biologics License Application by Organon LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BILPREVDA (DENOSUMAB)

Snippet

ORIG AP for BILPREVDA (DENOSUMAB)